UMass Chan Affiliations
Department of Medicine, Division of Hospital MedicineDocument Type
Accepted ManuscriptPublication Date
2020-04-14Keywords
cardiac drugsCOVID-19
coronavirus
mortality
angiotensin receptor blockers
pathogenesis
letter to the editor
Cardiology
Cardiovascular Diseases
Infectious Disease
Virus Diseases
Metadata
Show full item recordAbstract
We read with much interest the article “Are certain drugs associated with enhanced mortality in COVID -19” by Goldstein et al your esteemed Journal. Authors have discussed the theoretical basis of angiotensin receptor blockers, statins in worsening outcome of COVID – 19 patients.(1) We believe that this topic is rapidly evolving and requires further evidence and discussion for understanding the multiple factors which contribute to the pathogenesis and outcome. We have the following comments.Source
Mishra AK, Sahu KK, Sargent J. Cardiac drugs and outcome in COVID - 19. QJM. 2020 Apr 14:hcaa127. doi: 10.1093/qjmed/hcaa127. Epub ahead of print. PMID: 32289168. Link to article on publisher's site
DOI
10.1093/qjmed/hcaa127Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27314PubMed ID
32289168Related Resources
Rights
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. Accepted manuscript posted after 12 months as allowed by publisher's self-archiving policy at https://academic.oup.com/journals/pages/self_archiving_policy_bae974a485f413a2113503eed53cd6c53
10.1093/qjmed/hcaa127